Bharat Biotech EGF approval deferred till next meeting of GEAC
THE Hyderabad-based Bharat Biotech will have to wait some more time before taking its rDNA Epidermal Growth Factor (EGF) products to the market.

US FDA inspects Orchid’s formulations plant
The US FDA has inspected the state-of-the-art formulations facility of the Chennai-based Orchid Chemicals & Pharmaceuticals Ltd, located at Irungattukottai, for manufacturing a range of oral and sterile cephalosporin formulation products.

Kopran set to rope in Rabo Bank
Mumbai-based domestic pharmaceutical company Kopran’s efforts to recast its debt seems to be seeing some results.

Glenmark Labs merge operations with TASC Pharma
City-based Glenmark Laboratories Ltd and Tasc Pharmaceuticals Ltd have amalgamated their operations to form a combined entity that will have a presence in the entire pharmaceutical value chain.

Ranbaxy splits R&D chief post, opts for dual reporting structure
RANBAXY Laboratories decided to opt for an R&D structure that would do away with the need for a research head. Following the exit of Dr Rajinder Kumar (erstwhile head - R&D), there was some uncertainty about who would step into his shoes.

Wockhardt gets US FDA approval for famotidine 10 mg
Wockhardt Ltd, a pharmaceutical and biotechnology major, received US FDA approval for marketing the OTC (over-the-counter) version of famotidine, an anti-ulcer drug, in the US market.

Dishman set to acquire UK company
Dishman Pharmaceuticals and Chemicals Ltd is set for a strategic acquisition with an UK-based contract research company through its 100 per cent wholly owned subsidiary company namely Dishman Europe Ltd.

Nicholas Piramal to issue rights shares
The Board of Directors of Nicholas Piramal India Limited has approved a rights issue of equity shares to the company’s shareholders. The rights issue will raise equity funds not exceeding Rs 3,500 million.

Elder launches nicotine replacement therapy gum
City-based Elder Pharmaceuticals Ltd has launched NuLife (nicotine polacrilex USP) chewing gum, a nicotine replacement therapy product (NRT) for tobacco cessation in India.

SPI acquires Coimbatore-based MT business
SPI Technologies Inc, a leading global content outsourcing provider has acquired Coimbatore-based KG Information Services and Technologies Private Limited’s medical transcription business (KGMT).